WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007088190) BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/088190    International Application No.:    PCT/EP2007/050992
Publication Date: 09.08.2007 International Filing Date: 01.02.2007
IPC:
C07D 209/56 (2006.01), A61K 31/41 (2006.01), A61P 3/00 (2006.01), A61P 13/00 (2006.01), A61P 15/00 (2006.01), A61P 19/00 (2006.01), A61P 25/00 (2006.01), A61P 29/00 (2006.01), A61P 37/00 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (For All Designated States Except US).
BILLINTON, Andrew [GB/GB]; (GB) (For US Only).
CLAYTON, Nicholas, Maughan [GB/GB]; (GB) (For US Only).
GIBLIN, Gerard, Martin, Paul [GB/GB]; (GB) (For US Only).
HEALY, Mark Patrick [GB/GB]; (GB) (For US Only)
Inventors: BILLINTON, Andrew; (GB).
CLAYTON, Nicholas, Maughan; (GB).
GIBLIN, Gerard, Martin, Paul; (GB).
HEALY, Mark Patrick; (GB)
Agent: KING, Lawrence; GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS (GB)
Priority Data:
0602237.0 03.02.2006 GB
0608976.7 05.05.2006 GB
Title (EN) BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS
(FR) DÉRIVÉS DE L'ACIDE BENZO(F)ISOINDOL-2-YLPHÉNYL ACÉTIQUE COMME AGONISTES DU RÉCEPTEUR EP4
Abstract: front page image
(EN)A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1 R2 R3, R4, R5, R6, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
(FR)La présente invention concerne un composé de formule (I) ou un dérivé pharmaceutiquement acceptable de celui-ci, R1-, R2, R3, R4, R5, R6, X et Y étant tels que définis dans la description du brevet, un procédé pour la préparation de tels composés, une composition pharmaceutique comprenant de tels composés et l'utilisation de tels composés en médecine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)